Breast cancer sphingosine-1-phosphate is associated with phospho-sphingosine kinase 1 and lymphatic metastasis

Siegel, 2016, Cancer statistics, 2016, CA Cancer J Clin, 66, 7, 10.3322/caac.21332 Mumprecht, 2010, In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography, Cancer Res, 70, 8842, 10.1158/0008-5472.CAN-10-0896 Pham, 2010, Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning, J Exp Med, 207, 17, 10.1084/jem.20091619 Yoon, 2008, Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2+ signaling pathways, Blood, 112, 1129, 10.1182/blood-2007-11-125203 Nagahashi, 2010, Lymphangiogenesis: a new player in cancer progression, World J Gastroenterol, 16, 4003, 10.3748/wjg.v16.i32.4003 Nagahashi, 2012, Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis, Cancer Res, 72, 726, 10.1158/0008-5472.CAN-11-2167 Spiegel, 2003, Sphingosine-1-phosphate: an enigmatic signalling lipid, Nat Rev Mol Cell Biol, 4, 397, 10.1038/nrm1103 Spiegel, 2011, The outs and the ins of sphingosine-1-phosphate in immunity, Nat Rev Immunol, 11, 403, 10.1038/nri2974 Anelli, 2010, Role of sphingosine kinase-1 in paracrine/transcellular angiogenesis and lymphangiogenesis in vitro, Faseb J, 24, 2727, 10.1096/fj.09-150540 Nagahashi, 2015, DNA damage response and sphingolipid signaling in liver diseases, Surg Today Takabe, 2014, Export of sphingosine-1-phosphate and cancer progression, J Lipid Res, 55, 1839, 10.1194/jlr.R046656 Nagahashi, 2014, Sphingosine-1-phosphate transporters as targets for cancer therapy, Biomed Res Int, 2014, 651727, 10.1155/2014/651727 Takabe, 2008, “Inside-out” signaling of sphingosine-1-phosphate: therapeutic targets, Pharmacol Rev, 60, 181, 10.1124/pr.107.07113 Pitson, 2005, Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling, J Exp Med, 201, 49, 10.1084/jem.20040559 Takabe, 2010, Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2, J Biol Chem, 285, 10477, 10.1074/jbc.M109.064162 Yamada, 2013, High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival, Breast Cancer Res Treat, 137, 773, 10.1007/s10549-012-2398-5 Ruckhaberle, 2008, Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer, Breast Cancer Res Treat, 112, 41, 10.1007/s10549-007-9836-9 Shida, 2008, Targeting SphK1 as a new strategy against cancer, Curr Drug Targets, 9, 662, 10.2174/138945008785132402 Kim, 2009, Export and functions of sphingosine-1-phosphate, Biochim Biophys Acta, 1791, 692, 10.1016/j.bbalip.2009.02.011 Kowalski, 2013, Plasma sphingosine-1-phosphate is elevated in obesity, PLoS One, 8, e72449, 10.1371/journal.pone.0072449 Hait, 2009, Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate, Science, 325, 1254, 10.1126/science.1176709 2010 Schwab, 2005, Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients, Science, 309, 1735, 10.1126/science.1113640 Pappu, 2007, Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate, Science, 316, 295, 10.1126/science.1139221 Grigorova, 2010, Lymph node cortical sinus organization and relationship to lymphocyte egress dynamics and antigen exposure, Proc Natl Acad Sci U S A, 107, 20447, 10.1073/pnas.1009968107 Ono, 2013, Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration, Lipids Health Dis, 12, 20, 10.1186/1476-511X-12-20 Yatomi, 2004, Sphingosine 1-phosphate breakdown in platelets, J Biochem, 136, 495, 10.1093/jb/mvh143 Bode, 2010, Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1-phosphate, J Cell Biochem, 109, 1232 Hanel, 2007, Erythrocytes store and release sphingosine 1-phosphate in blood, Faseb J, 21, 1202, 10.1096/fj.06-7433com Ogretmen, 2004, Biologically active sphingolipids in cancer pathogenesis and treatment, Nat Rev Cancer, 4, 604, 10.1038/nrc1411 Pyne, 2010, Sphingosine 1-phosphate and cancer, Nat Rev Cancer, 10, 489, 10.1038/nrc2875 Aoyagi, 2012, The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesis, Lymphat Res Biol, 10, 97, 10.1089/lrb.2012.0010 Takabe, 2012, Twofer anti-vascular therapy targeting sphingosine-1-phosphate for breast cancer, Gland Surg, 1, 80 Liang, 2013, Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer, Cancer Cell, 23, 107, 10.1016/j.ccr.2012.11.013 Long, 2010, Sphingosine kinase 1 induces tolerance to human epidermal growth factor receptor 2 and prevents formation of a migratory phenotype in response to sphingosine 1-phosphate in estrogen receptor-positive breast cancer cells, Mol Cell Biol, 30, 3827, 10.1128/MCB.01133-09 Long, 2010, Sphingosine 1-phosphate receptor 4 uses HER2 (ERBB2) to regulate extracellular signal regulated kinase-1/2 in MDA-MB-453 breast cancer cells, J Biol Chem, 285, 35957, 10.1074/jbc.M110.117945 Ohotski, 2012, Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer, Br J Cancer, 106, 1453, 10.1038/bjc.2012.98 Datta, 2014, SPHK1 regulates proliferation and survival responses in triple-negative breast cancer, Oncotarget, 5, 5920, 10.18632/oncotarget.1874 Pruneri, 2016, Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer, Ann Oncol, 27, 249, 10.1093/annonc/mdv571 Wang, 1999, Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor. Potential involvement in angiogenesis, J Biol Chem, 274, 35343, 10.1074/jbc.274.50.35343 Huang, 2013, Emerging role of sphingosine-1-phosphate in inflammation, cancer, and lymphangiogenesis, Biomolecules, 3, 408, 10.3390/biom3030408 Nagahashi, 2014, Sphingosine-1-phosphate in chronic intestinal inflammation and cancer, Adv Biol Regul, 54, 112, 10.1016/j.jbior.2013.10.001 Schwab, 2007, Finding a way out: lymphocyte egress from lymphoid organs, Nat Immunol, 8, 1295, 10.1038/ni1545 Zachariah, 2010, Neural crest-derived pericytes promote egress of mature thymocytes at the corticomedullary junction, Science, 328, 1129, 10.1126/science.1188222 Kunkel, 2013, Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond, Nat Rev Drug Discov, 12, 688, 10.1038/nrd4099 Maceyka, 2014, Sphingolipid metabolites in inflammatory disease, Nature, 510, 58, 10.1038/nature13475 Denimal, 2015, Significant abnormalities of the HDL phosphosphingolipidome in type 1 diabetes despite normal HDL cholesterol concentration, Atherosclerosis, 241, 752, 10.1016/j.atherosclerosis.2015.06.040 Argraves, 2011, S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease, Lipids Health Dis, 10, 70, 10.1186/1476-511X-10-70